ProductSafer
Subscribe
⚠️

Official Product Recall

This notice was issued by U.S. Food & Drug Administration (FDA).

FDA

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.

This recall was published by U.S. Food & Drug Administration (FDA). View the full official notice for complete details, affected product codes, and what to do next.

View full recall notice

Get an email when another product is recalled

A free Sunday round-up of new UK and US product recalls and safety warnings. Unsubscribe any time.

What should I do?

  • 1.Stop using the product immediately if you have it.
  • 2.Check the full recall notice for affected batch numbers, UPCs, or model numbers.
  • 3.Follow the instructions in the recall notice for returns, replacements, or disposal.
  • 4.If you have health concerns after using the product, contact your GP or call NHS 111.
Back to all recalls

ProductSafer is not affiliated with the FDA. This page reproduces publicly available recall information.

Never miss a finding

Get the latest health findings delivered to your inbox. Only the important stuff. No spam.

We'll send a confirmation email. Unsubscribe anytime.